OBJECTIVE: We sought to evaluate the impact of obesity on the management and outcomes of postpartum hemorrhage. STUDY DESIGN: We conducted a retrospective cohort study including all women who delivered at a tertiary center during 2/1/2013-12/31/ 2014. Medical charts were reviewed for clinical and sociodemographic data. Hemorrhage related severe morbidity indicators included blood transfusion, shock, acute renal failure, transfusion related lung injury, cardiac arrest and use of interventional radiology procedures. Obese (BMI30kg/m 2 ) and nonobese women were compared. The data was analyzed using chi-square, student t-test, Mann Whitney U test, and logistic regression where appropriate. P < 0.05 was significant. RESULTS: There were 9,890 deliveries and 2.9% (n¼287) were complicated by obstetric hemorrhage. The sample population of obese and non-obese women did not differ in race, ethnicity or insurance status. The obese women with hemorrhage were more likely to have a macrosomic infant (18.6 vs. 8.9%, p¼0.03), have delivered by cesarean section, (71% vs 29%, p¼0.008), undergo a cesarean section after labor (30.4% vs 11.9%, p¼0.001), and have a higher quantitative blood loss (1281 vs 1042 ml, p¼.01). Both groups were equally likely to receive carboprost, methylergonovine and misoprostol but obese women were more likely to need >2 doses of uterotonic agents (66% vs. 34%, p¼0.04). There was no difference in the decision to proceed to the operating room (11.8 % vs 20.5%, p¼0.39), Bakri balloon (11.8% and 7.7%, p¼0.72), use of interventional radiology (5.8% vs 6.5%, p¼0.99), or the decision to proceed with hysterectomy (8% vs 5.2%, p¼0.57). The two groups were similar in the time to first treatment and time to stabilization, and there was no difference in the need for blood transfusion (29.2 vs 24.7, p¼.47) or number of units of blood transfused (2.2 vs. 2.1 units, p¼.25). Obese women were equally likely to experience a severe morbidity (50.5% vs 41%, p¼0.34), but more likely to experience more than one severe morbidity (28.4% vs 10.3%, p¼0.03). After controlling for confounding variables, time to stabilization (hr.) [or 1.06 (95%CI 1.006-1.13)], and admission hemoglobin ] neither obesity nor management were predictive of severe morbidity. CONCLUSION: Compared to normal weight women, obese women with postpartum hemorrhage required more doses of uterotonic agents and had more severe morbidity despite similar management.
Vacuum vs. forceps: A two-delivery cost-effectiveness analysis
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Oregon Health & Science University, Portland, OR OBJECTIVE: Operative vaginal delivery using forceps or vacuum is a common approach to the management of the prolonged second stage. Each method carries its own risks of neonatal and maternal morbidity. Our study examined the cost-effectiveness of forceps compared to vacuum in the context of two deliveries. STUDY DESIGN: A cost-effectiveness model was created using TreeAge 2018 software to compare neonatal and maternal outcomes of forceps delivery compared to vacuum delivery considering the impact on the subsequent pregnancy. We used a theoretical cohort of 100,000 women, the approximate number of nulliparous term births in the US annually affected by prolonged second stage of labor. We assumed all women proceeded to a second delivery, reflecting the average number of births per woman in the US. Outcomes included neonatal mortality, permanent brachial plexus injury (BPI), severe cerebral morbidity (CM), maternal mortality, severe perineal laceration, placenta previa, placenta accreta, uterine rupture, hysterectomy, cost, and quality-adjusted life years (QALY) of the woman and neonate. Probabilities, utilities, and costs were derived from the literature, and the willingness-to-pay (WTP) threshold was $100,000/QALY. Univariate sensitivity analysis was used to assess the robustness of the results. RESULTS: Comparing forceps to vacuum in a woman's first delivery, forceps was cost-effective (increased QALYs despite increased costs) when considering a primary and a subsequent delivery. In our theoretical cohort of 100,000 women, forceps delivery led to 10,163 fewer cesarean sections across two deliveries, 71 fewer placenta previas and 9 fewer hysterectomies with 34,233 additional QALYs, despite an additional 14,762 severe perineal lacerations (Table 1) . Sensitivity analysis demonstrated that forceps remained the costeffective strategy up to a failure rate of vacuum of 0.15 (with a baseline of 0.06) (Figure 1 ). The incremental cost-effectiveness ratio (ICER) was $1,345/QALY. CONCLUSION: In our theoretical cohort, utilizing forceps as compared to vacuum leads to fewer adverse outcomes, increased QALYs and increased costs during the first and second delivery.
663 When is it optimal to stop pushing in prolonged second stage of labor? 
